NO996161D0 - A controlled release formulation for heavily soluble basic drugs - Google Patents

A controlled release formulation for heavily soluble basic drugs

Info

Publication number
NO996161D0
NO996161D0 NO996161A NO996161A NO996161D0 NO 996161 D0 NO996161 D0 NO 996161D0 NO 996161 A NO996161 A NO 996161A NO 996161 A NO996161 A NO 996161A NO 996161 D0 NO996161 D0 NO 996161D0
Authority
NO
Norway
Prior art keywords
controlled release
release formulation
soluble basic
basic drugs
heavily soluble
Prior art date
Application number
NO996161A
Other languages
Norwegian (no)
Other versions
NO310095B1 (en
NO996161L (en
Inventor
Neville W Broad
Alan F Carmody
Liam C Feely
Brian C Withers
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to NO996161A priority Critical patent/NO310095B1/en
Publication of NO996161L publication Critical patent/NO996161L/en
Publication of NO996161D0 publication Critical patent/NO996161D0/en
Publication of NO310095B1 publication Critical patent/NO310095B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
NO996161A 1997-06-11 1999-12-13 A controlled release formulation for heavily soluble basic drugs NO310095B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO996161A NO310095B1 (en) 1997-06-11 1999-12-13 A controlled release formulation for heavily soluble basic drugs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1997/010705 WO1998056357A1 (en) 1995-12-19 1997-06-11 A controlled release formulation for poorly soluble basic drugs
NO996161A NO310095B1 (en) 1997-06-11 1999-12-13 A controlled release formulation for heavily soluble basic drugs

Publications (3)

Publication Number Publication Date
NO996161L NO996161L (en) 1999-12-13
NO996161D0 true NO996161D0 (en) 1999-12-13
NO310095B1 NO310095B1 (en) 2001-05-21

Family

ID=22261117

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996161A NO310095B1 (en) 1997-06-11 1999-12-13 A controlled release formulation for heavily soluble basic drugs

Country Status (4)

Country Link
NO (1) NO310095B1 (en)
SI (1) SI20108B (en)
SK (1) SK282427B6 (en)
WO (1) WO1998056357A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3668000A (en) * 1999-04-29 2000-11-17 Russinsky Limited Compounds
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
RU2279439C2 (en) * 2000-11-27 2006-07-10 Сандоз Аг Azithromycin monohydrate and method for its preparing
AU2003214504A1 (en) * 2002-04-03 2003-10-13 Ranbaxy Laboratories Limited Taste masked compositions of erythromycin a and derivatives thereof
SI21300A (en) * 2002-10-08 2004-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical compositions with alginates
CN100336511C (en) * 2002-11-15 2007-09-12 江苏豪森药业股份有限公司 Release-controlled oral Roxithromycin formulation
AU2004249211A1 (en) * 2003-06-16 2004-12-29 Andrx Pharmaceuticals, Llc Oral extended-release composition
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (en) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60163823A (en) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd Oral administration pharmaceutical
ATE66143T1 (en) * 1985-01-11 1991-08-15 Abbott Lab SLOW RELEASE SOLID PREPARATION.
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs

Also Published As

Publication number Publication date
NO310095B1 (en) 2001-05-21
NO996161L (en) 1999-12-13
WO1998056357A1 (en) 1998-12-17
SI20108B (en) 2001-12-31
SK282427B6 (en) 2002-01-07
SK161299A3 (en) 2000-05-16
SI20108A (en) 2000-06-30

Similar Documents

Publication Publication Date Title
HUP9800516A3 (en) A controlled release formulation for poorly soluble basic drugs
MA26576A1 (en) EXTENDED RELEASE ORAL PHARMACEUTICAL FORMULATION
MA26577A1 (en) PULSED RELEASE ORAL PHARMACEUTICAL FORMULATION
NO20000735D0 (en) Sustained release drug delivery device
ATE234078T1 (en) PHARMACEUTICAL OMEPRAZOLE FORMULATION
EE04294B1 (en) A pharmaceutical composition for combining piperidinoalkanol decongestant
EP1124543A4 (en) Controlled release formulation for water soluble drugs
FIU20000164U0 (en) A new pharmaceutical formulation
EE200000361A (en) Device for administering a drug-containing fluid
DE69904312T2 (en) PHARMACEUTICAL AEROSOL FORMULATION
BR9607752B1 (en) controlled release microcapsule pharmaceutical formulation.
ZA982872B (en) Pharmaceutical formulation
NO996161L (en) A controlled release formulation for heavily soluble basic drugs
NO20002126L (en) Extended release formulation
NO20001375L (en) Drug formulation with controlled release
HK1045465A1 (en) A pharmaceutical formulation comprising megalatranand its prodrug
PT868911E (en) RAPAMICINE FORMULATIONS FOR ORAL ADMINISTRATION
AU5026599A (en) A wet granulation method for preparing a stable pharmaceutical formulation
ID30032A (en) PHARMACEUTICAL FORMULATION
NO996044L (en) Rapamycin formulations for oral administration
GB9709739D0 (en) Pharmaceutical formulation
NO980072D0 (en) Soluble release mechanism for moving joints
HRP970325B1 (en) Controlled release formulation for poorly soluble basic drugs
GB9724175D0 (en) A pharmaceutical formulation
GB9811622D0 (en) Drug formulation

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BGP PRODUCTS OPERATIONS GMBH, CH

MK1K Patent expired